Anthem confident, but experts see antitrust hurdles to Cigna deal

NEW YORK/WASHINGTON (Reuters) - U.S. health insurer Anthem Inc on Monday dismissed concerns that buying smaller competitor Cigna Corp would be considered anti-competitive, even as antitrust experts said the combination would earn regulatory scrutiny.